Peter Lynch fit · Growth at a reasonable price (GARP)
Is GSK plc (GSK.L) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria - growth too low or price too high.
31/100
FNot a fit
2/6 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 23 → lifted to 31 before grade derivation.
Peter Lynch's Criteria, Applied to GSK.L
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-27.6%
Revenue CAGR ≥ 10%
3.7%
Net margin > 0
17.5%
Manageable debt (D/E < 1)
1.1x
Positive free cash flow
Yes
How GSK.L Scores on Other Strategies
Live Financial Snapshot
Market cap
$73.92B
P/E (TTM)
13.2x
ROIC (TTM)
17.79%
Gross margin
72.4%
Other Peter Lynch fit reports
Frequently Asked Questions
What is GSK.L's Peter Lynch fit score?
GSK.L scores 31/100 on our Peter Lynch fit engine - grade F. Does not fit Lynch's GARP criteria - growth too low or price too high.
Does Peter Lynch actually own GSK.L?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends GSK.L.
How often is this score updated?
GSK.L's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends GSK.L.